BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Dacarbazine

An antineoplastic agent. It has significant activity against melanomas. (from Martindale, The Extra Pharmacopoeia, 31st ed, p564)

299+ PubMed studies analyzed · 45 RCTs · Evidence Score: 50.7

Research Domains

Dacarbazine has been studied across 12 research domains including 🔬 Oncology, ✨ Skin & Hair, ⏳ Longevity & Aging, 🛡️ Immunity, 🫁 Liver & Detox. The primary research focus is 🔬 Oncology with 57% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Dacarbazine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Aztreonam
4 shared targets
Pinacidil
4 shared targets
Midodrine
4 shared targets
Carbimazole
4 shared targets
Lactic
4 shared targets
Metaraminol
4 shared targets
Modafinil
4 shared targets
Ethanolamine
5 shared targets
Sulfadoxine
4 shared targets
Iodine
4 shared targets
Loading evidence profile...

This evidence profile for Dacarbazine is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.